In agreement with western blot data, increased immunoreactivity for eIF4A1 was detected ubiquitously in HCC lesions compared to that in the matching non-neoplastic liver tissues (Figure 4, first lower panel). This evidence concerns the gene EIF4A1 and hepatocellular carcinoma.